Maria Mar Hernandez Guillamon

Senior Researcher, Neurovascular Research Lab, VHIR.

Instituciones de las que forman parte

Investigador/a principal
Enfermedades Neurovasculares

Vall Hebron Institut de Recerca

Maria Mar Hernandez Guillamon

Instituciones de las que forman parte

Investigador/a principal
Enfermedades Neurovasculares

Vall Hebron Institut de Recerca

Senior Researcher, Neurovascular Research Lab, VHIR.

Dr. Mar Hernández-Guillamon has dedicated her career to the study of cerebral amyloid angiopathy (CAA) and other pathologies associated with the deposition of amyloid-beta (Abeta). In 2013, she was awarded by Carlos III Spanish Health Institute with the Miguel Servet contract to establish the Cerebral Amyloidosis line of research at VHIR. Her group has positioned in forefront of the Abeta-pathologies field, studying the molecular mechanisms involved in the Abeta transport and metabolism using in vitro and in vivo models. Her lab has also dedicated to the clinical research and discovery of biomarkers associated with CAA and other cerebrovascular diseases. The translational research developed by Dr. Hernandez-Guillamon's group has allowed the achievement of important aims to date, as demonstrated by the scientific production obtained (h-index= 35, 80 publications, >3700 citations) and the continuous leadership of national and international projects.

Proyectos

Incorporació Dr. Joan Montaner a la RETICS en Malalties vasculars cerebrals (ICTUS)

IP: -
Colaboradores: Anna Rosell Novel, Mercedes Arrúe Gonzalo, Anna Penalba Morenilla, Maria Mar Hernandez Guillamon, Maria Pilar Delgado Martínez, Guillem Colell Dinares, Anna Rosell Novel, Anna Rosell Novel, Anna Rosell Novel, Anna Rosell Novel, Anna Rosell Novel, Anna Rosell Novel, Anna Rosell Novel, Anna Rosell Novel, Anna Rosell Novel, Anna Rosell Novel, Anna Rosell Novel, Anna Rosell Novel, Anna Rosell Novel, Anna Rosell Novel, Anna Rosell Novel, Anna Rosell Novel, Anna Rosell Novel, Anna Rosell Novel, Anna Rosell Novel, Anna Rosell Novel, Anna Rosell Novel, Anna Rosell Novel, Anna Rosell Novel, Anna Rosell Novel, Anna Rosell Novel, Anna Rosell Novel, Anna Rosell Novel, Anna Rosell Novel, Anna Rosell Novel, Anna Rosell Novel, Anna Rosell Novel, Anna Rosell Novel, Anna Rosell Novel, Anna Rosell Novel, Anna Rosell Novel, Anna Rosell Novel, Anna Rosell Novel
Entidad financiadora: Instituto de Salud Carlos III
Financiación: 240669
Referencia: RD16/0019/0021
Duración: 01/01/2017 - 31/12/2021

Interplay of amyloid and ischemia and their influence on blood-brain barrier, amyloid transportation systems and neurodegeneration in cerebral amyloid angiopathy (CAA)

IP: Maria Mar Hernandez Guillamon
Colaboradores: -
Entidad financiadora: Instituto de Salud Carlos III
Financiación: 65340
Referencia: AC15/00030
Duración: 01/01/2016 - 30/11/2020

Malalties Neurovasculars (GRC)

IP: Joan Montaner Villalonga
Colaboradores: Marta Aurora Rubiera Del Fueyo, Jorge Pagola Pérez Blanca, José Alvarez Sabin, Anna Penalba Morenilla, Maria Mar Hernandez Guillamon, Marc Ribó Jacobi, Maria Pilar Delgado Martínez, Carlos Molina Cateriano, Anna Rosell Novel, David Rodriguez Luna, Mª Ángeles Muchada López, Estevo Santamarina Pérez, Manuel Quintana Luque
Entidad financiadora: Agència Gestió Ajuts Universitaris i de Recerca
Financiación: 48000
Referencia: 2014 SGR 686
Duración: 01/01/2014 - 31/12/2016

Marcadores radiológicos y biológicos de disfunción cerebrovascular en la Angiopatía Amiloide Cerebral

IP: Maria Mar Hernandez Guillamon
Colaboradores: Jessica Camacho Soriano
Entidad financiadora: Instituto de Salud Carlos III
Financiación: 98615
Referencia: PI14/01134
Duración: 01/01/2015 - 31/05/2018